NCT00320970View on ClinicalTrials.gov

Angiotensin II Antagonism of TGF-Beta 1

NACompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

September 30, 2004

Conditions

Diabetic NephropathyHypertension

Interventions

DRUG

Candesartan

Trial Locations (1)

99204

Providence Medical Research Center, Spokane

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Providence Health & Services

OTHER